Marco Oderda

Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients

Paolo Gontero, Richard Sylvester, Francesca Pisano et al. · European Urology · 2014 · 241 citations

Prognostic Factors, Urological Research, Urology +8

The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin

Paolo Gontero, Richard Sylvester, Francesca Pisano et al. · British Journal of Urology · 2015 · 150 citations · Full text

Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches

Paolo Gontero, Giancarlo Marra, Paolo Alessio et al. · The Journal of Urology · 2019 · 89 citations

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial

Paolo Gontero, Marco Oderda, Anja Mehnert et al. · The Journal of Urology · 2013 · 78 citations

microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes

Barbara Pardini, Francesca Cordero, Alessio Naccarati et al. · Oncotarget · 2018 · 78 citations · Full text